Astrocytoma
📧 Sign up to get email alerts when something new happens for Astrocytoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-27EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) from Les Laboratoires Servier has been authorised by the EMA for certain gliomas, including oligodendroglioma and ast…
-
EMA approval · 2026-07-21EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for oligodendroglioma and astrocytoma by Les Laboratoires Servier.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigational Imaging Technique During Brain Surgery [NA]
A clinical trial evaluating an investigational imaging technique during brain tumor surgery has been suspended. The study involves astrocyto…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas [Phase 1]
This update describes a Phase 1 clinical trial evaluating locoregional administration of EGFR/IL13Rα2 Pool-CAR T cells for recurrent or prog…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
This Clinical Trial Update describes a Phase 1 study of hypofractionated re-irradiation for good-prognosis recurrent glioblastoma, sponsored…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Pediatric Long-Term Follow-up and Rollover Study [Phase 4]
Pediatric long-term follow-up and rollover study (Phase 4) sponsored by Novartis is active but not recruiting, tracking outcomes in children…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Tuvusertib in Astrocytoma With ATRX Mutation [Phase 2]
A phase 2 trial of Tuvusertib in astrocytoma with ATRX mutation is currently recruiting. The study is sponsored by Grupo Español de Investig…
-
EMA approval · 2026-03-18EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for the treatment of oligodendroglioma and astrocytoma, with orphan medicine designatio…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma [Phase 1]
Phase 1 study evaluating vorasidenib in combination with pembrolizumab for recurrent or progressive IDH-1 mutant gliomas (astrocytoma and ol…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma [Phase 1]
A Phase 1 trial evaluating the addition of AZD1390 to radiation therapy for newly diagnosed pediatric high-grade gliomas, including diffuse …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]
Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status cur…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. [Phase 2]
A Phase 2 clinical trial update for pre-radiation chemotherapy in newly diagnosed high-grade gliomas, including glioblastoma, astrocytoma, a…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma [Phase 2]
Phase 2 clinical trial assessing the combination of All-Trans Retinoic Acid (ATRA) with a PD-1 inhibitor in recurrent IDH-mutant glioma; rec…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of CVGBM in adults with newly diagnosed MGMT-unmethylated glioblastoma or astrocytoma…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Venous Thromboembolism Prevention in Outpatients With Glioma [Phase 2]
A Phase 2 clinical trial is updating recruitment status for venous thromboembolism prevention in outpatients with glioma, including glioblas…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma [Phase 1]
Phase 1 trial evaluating mycophenolate mofetil in combination with standard of care for glioblastoma; study status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. [Phase 1]
Phase 1 trial update on an adenovirus-mediated suicide gene therapy combined with radiotherapy for progressive astrocytoma; the study is cur…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial [Phase 2]
This Phase IIc randomized feasibility pilot trial evaluated cognitive behavioral therapy for insomnia in patients with primary brain tumors …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma [NA]
Clinical trial update evaluating an ex vivo drug combination optimization platform for recurrent high-grade astrocytic glioma, currently rec…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of How Safe and Effective Tarlatamab is in Brain Cancers [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of tarlatamab in brain cancers is currently recruiting. The study targets ast…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
The clinical trial investigating microRNA-10b expression in glioma patients has been terminated.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: FearLess in NeuroOncology [NA]
Clinical trial update for FearLess in NeuroOncology indicates the study is currently recruiting for patients with glioblastoma and other pri…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
APPEAR is a clinical trial evaluating amino acid PET-based response assessment in IDH-mutant gliomas and is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Implantable Microdevice In Primary Brain Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating an implantable microdevice for primary brain tumors is currently recruiting across multiple gliom…